Stock listing

BOATS:RGNX Regenxbio Inc. Stock

US listing (BOATS) of Regenxbio Inc. · home listing NASDAQ:RGNX

Follow Regenxbio Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:RGNX

$7.15 USD +0.23 (+3.2%)

Close on Oct 19, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RGNX

Past 3 months -51.8% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
$6.95 – $7.27 USDOct 19, 2026
Volume
1.30M sharesOct 19, 2026
Market cap
$472.0M USDAt the close on Oct 19, 2026 · price × 66.01M shares outstanding
Regenxbio Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:RGNX · Home$7.15 USD+0.225 (+3.2%)1,297,966$6.98$7.265$6.95$6.925Close on Oct 19, 2026
Frankfurt:RB0€6.192 EUR-0.112 (-1.8%)—€6.192€6.192€6.192€6.304Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:RGNX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$7.15+0.225+3.2%$6.98$7.265$6.951,297,966
$6.925-0.235-3.3%$7.15$7.18$6.8751,210,187
$7.16+0.28+4.1%$6.88$7.28$6.831,228,241
$6.88-0.38-5.2%$7.12$7.24$6.801,557,940
$7.26-0.51-6.6%$7.66$7.72$7.111,378,262
$7.77-0.30-3.7%$8.12$8.29$7.742,033,555
$8.07-0.02-0.2%$8.03$8.275$7.95859,286
$8.09+0.495+6.5%$7.50$8.31$7.442,258,957
$7.595+0.145+1.9%$7.31$7.73$7.201,004,900
$7.45-0.31-4.0%$7.79$7.84$7.331,164,100
$7.76+0.33+4.4%$7.80$8.16$7.572,349,800
$7.43+0.01+0.1%$7.58$7.62$7.361,036,600
$7.42-0.11-1.5%$7.52$7.736$7.301,705,100
$7.53+0.08+1.1%$7.49$7.86$7.351,788,600
$7.45-0.02-0.3%$7.41$7.64$7.332,095,900
$7.47+0.07+0.9%$7.30$7.495$7.171,325,800
$7.40+0.16+2.2%$7.53$7.675$7.1651,276,500
$7.24-0.26-3.5%$7.45$7.46$7.121,509,200
$7.50-0.65-8.0%$8.13$8.145$7.401,112,900
$8.15+0.27+3.4%$8.03$8.25$7.9041,202,500
$7.88-0.15-1.9%$8.24$8.313$7.761,115,700
$8.03-0.185-2.3%$8.22$8.331$8.003,374,800
$8.215+0.235+2.9%$8.34$8.56$8.021,808,100
$7.98+0.035+0.4%$7.93$7.99$7.6361,231,600
$7.945-0.745-8.6%$8.69$8.75$7.781,426,600
$8.69+0.16+1.9%$8.58$8.728$8.49858,400
$8.53-0.03-0.4%$8.69$8.82$8.391,029,100
$8.56-0.17-1.9%$8.63$8.79$8.471,172,100
$8.73-0.03-0.3%$8.70$9.025$8.621,407,400
$8.76-0.18-2.0%$8.95$8.95$8.60998,700
$8.94-0.26-2.8%$9.09$9.215$8.861,069,100
$9.20-0.40-4.2%$9.56$9.56$9.00839,200
$9.60+0.28+3.0%$9.34$9.708$9.20866,300
$9.32-0.18-1.9%$9.38$9.616$9.28783,700
$9.50-0.16-1.7%$9.50$9.68$9.091,611,400
$9.66+0.29+3.1%$10.00$10.10$9.2121,752,500
$9.37-0.01-0.1%$9.35$9.46$9.04916,600
$9.38+0.47+5.3%$8.85$9.43$8.611,160,000
$8.91+0.855+10.6%$8.14$8.99$8.131,756,781
$8.055-2.665-24.9%$8.29$8.64$7.775,446,547
$10.72-0.34-3.1%$11.14$11.16$10.491,005,500
$11.06-0.96-8.0%$11.98$12.08$11.03947,300
$12.02+0.95+8.6%$11.50$12.04$11.501,146,900
$11.07-0.26-2.3%$11.13$11.20$10.73623,900
$11.33+0.565+5.2%$10.69$11.36$10.531,042,000
$10.77+0.105+1.0%$10.68$10.86$10.34792,500
$10.66-0.25-2.3%$11.03$11.25$10.61805,600
$10.91+0.26+2.4%$10.77$11.21$10.68877,100
$10.65+0.23+2.2%$10.56$10.79$10.15881,100
$10.42-0.30-2.8%$10.52$10.87$10.27988,800
$10.72-0.56-5.0%$11.05$11.39$10.311,387,900
$11.28+0.78+7.4%$11.28$11.50$10.851,769,200
$10.50+0.20+1.9%$10.32$10.79$10.201,522,000
$10.30+0.34+3.4%$10.13$10.43$9.871968,700
$9.96+0.27+2.8%$9.75$10.01$9.31812,900
$9.69-0.43-4.2%$10.25$10.38$9.6351,157,400
$10.12+0.50+5.2%$9.75$10.14$9.531,215,100
$9.62+0.02+0.2%$9.65$9.90$9.461,088,000
$9.60-0.11-1.1%$9.59$9.77$9.1751,389,400
$9.71-0.02-0.2%$10.05$10.51$9.6551,248,600
$9.73-0.52-5.1%$10.24$10.34$9.57974,300
$10.25+0.05+0.5%$9.94$10.32$9.6751,364,600
$10.20-0.14-1.4%$10.08$10.50$10.011,153,400
$10.34+0.02+0.2%$10.19$10.49$9.9211,980,710
$10.32+0.43+4.3%$10.01$10.78$10.012,280,553
Ticker
BOATS:RGNX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BOATS
Currency
USD

What changed lately

Calls

Replays

  • REGENXBIO (NASDAQ:RGNX) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 8:00 AM ET

    Watch Transcript
  • REGENXBIO (NASDAQ:RGNX) Q1 2026 Earnings Call

    Thu, May 14, 2026 · 8:00 AM ET

    Watch Transcript
  • REGENXBIO (NASDAQ:RGNX) Q4 2025 Earnings Call

    Thu, Mar 05, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

All Regenxbio Inc. news

Financings

  • Public offering of common stock and pre-funded warrants

    Aug 6, 2026

    Closed: US$108M raised · US$9 a share · Morgan Stanley +3

    Dealers: Morgan Stanley (co-lead), J.P. Morgan (co-lead), Leerink Partners (co-lead), Mizuho (co-lead)

    Use of proceeds: Extend cash runway into Q4 2027 and support the planned AFFINITY RISE ex-U.S. randomized-controlled trial of RGX-202 in 1H 2027

    Announced Jul 17, 2026 · Closed Aug 6, 2026

Read by 6ix AI from the company's releases

Decks

Regenxbio Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
26 in the last 12 months · 220 in all · newest Oct 12, 2026 · oldest 2019
Calls
24 calls with a replay · 24 with a transcript · latest Aug 6, 2026
Decks
14 decks · latest September 2026

Where Regenxbio Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:RGNX · Home listingNASDAQUnited StatesUSD
gettex:RB0gettexGermanyEUR
LS Exchange:A140E0LS ExchangeGermanyEUR
Tradegate:RB0TradegateGermanyEUR
Lang & Schwarz:A140E0Lang & SchwarzGermanyEUR
Frankfurt:RB0FrankfurtGermanyEUR
BOATS:RGNX · This pageBOATSUnited StatesUSD
Munich:RB0MunichGermanyEUR
Dusseldorf:RB0DusseldorfGermanyEUR
Stuttgart:RB0StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Regenxbio Inc.